Healthcare provider profile · identity verified

Lee H Peck, MD

Hospitalist · JACKSONVILLE, FL · NPI 1619959749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	563	201
Amlodipine Besylate	Amlodipine Besylate	387	149
Rosuvastatin Calcium	Rosuvastatin Calcium	359	129
Lisinopril	Lisinopril	314	115
Losartan Potassium	Losartan Potassium	313	112
Levothyroxine Sodium	Levothyroxine Sodium	306	100
Tamsulosin Hcl	Tamsulosin Hcl	215	78
Albuterol Sulfate Hfa	Albuterol Sulfate	182	69
Gabapentin	Gabapentin	182	71
Prednisone	Prednisone	178	82
Metformin Hcl	Metformin Hcl	169	71
Pantoprazole Sodium	Pantoprazole Sodium	165	61
Omeprazole	Omeprazole	146	51
Fluticasone Propionate	Fluticasone Propionate	144	63
Hydrochlorothiazide	Hydrochlorothiazide	142	50
Duloxetine Hcl	Duloxetine Hcl	134	39
Sertraline Hcl	Sertraline Hcl	127	42
Carvedilol	Carvedilol	123	43
Metformin Hcl Er	Metformin Hcl	114	37
Metoprolol Succinate	Metoprolol Succinate	112	44
Trazodone Hcl	Trazodone Hcl	111	41
Alendronate Sodium	Alendronate Sodium	104	36
Metoprolol Tartrate	Metoprolol Tartrate	104	39
Zolpidem Tartrate	Zolpidem Tartrate	101	21
Potassium Chloride	Potassium Chloride	98	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	94	23
Eliquis	Apixaban	92	31
Furosemide	Furosemide	91	43
Ozempic	Semaglutide	89	20
Solifenacin Succinate	Solifenacin Succinate	89	28
Baclofen	Baclofen	87	37
Famotidine	Famotidine	85	34
Montelukast Sodium	Montelukast Sodium	83	34
Valsartan	Valsartan	82	28
Clopidogrel	Clopidogrel Bisulfate	80	28
Azithromycin	Azithromycin	74	30
Simvastatin	Simvastatin	74	26
Finasteride	Finasteride	70	23
Triamcinolone Acetonide	Triamcinolone Acetonide	66	30
Vitamin D2	Ergocalciferol (Vitamin D2)	66	28
Allopurinol	Allopurinol	60	20
Spironolactone	Spironolactone	60	21
Hydralazine Hcl	Hydralazine Hcl	55	19
Ondansetron Hcl	Ondansetron Hcl	53	23
Diclofenac Sodium	Diclofenac Sodium	50	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	22
Novolog Flexpen	Insulin Aspart	50	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	14
Meloxicam	Meloxicam	48	20
Tizanidine Hcl	Tizanidine Hcl	46	18
Celecoxib	Celecoxib	43	16
Escitalopram Oxalate	Escitalopram Oxalate	41	16
Nifedipine Er	Nifedipine	41	14
Jardiance	Empagliflozin	40	15
Nystatin	Nystatin	40	17
Citalopram Hbr	Citalopram Hydrobromide	39	11
Hydroxyzine Hcl	Hydroxyzine Hcl	39	13
Sildenafil Citrate	Sildenafil Citrate	39	16
Doxycycline Hyclate	Doxycycline Hyclate	38	33
Pregabalin	Pregabalin	38	15
Amitriptyline Hcl	Amitriptyline Hcl	36	11
Pioglitazone Hcl	Pioglitazone Hcl	36	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	24
Donepezil Hcl	Donepezil Hcl	33	12
Bupropion Xl	Bupropion Hcl	32	13
Mirtazapine	Mirtazapine	32	13
Pravastatin Sodium	Pravastatin Sodium	32	13
Ibuprofen	Ibuprofen	31	13
Memantine Hcl	Memantine Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Temazepam	Temazepam	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Atenolol	Atenolol	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	19
Clonidine Hcl	Clonidine Hcl	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Cephalexin	Cephalexin	23	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	18
Levetiracetam	Levetiracetam	23	suppressed
Cefdinir	Cefdinir	22	20
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Novolog	Insulin Aspart	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lactulose	Lactulose	17	12
Lorazepam	Lorazepam	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Colchicine	Colchicine	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	13
Lamotrigine	Lamotrigine	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error